PMI's IQOS and cigarette ads in Israel.

Dec.15.2022
PMI's IQOS and cigarette ads in Israel.
Philip Morris International (PMI) used legal loopholes to market smoking products to Orthodox Jewish communities in Israel.

The leading global tobacco company Philip Morris International (PMI) has taken advantage of a legal loophole in Israel's ban on advertising smoking products, targeting the extremely conservative Orthodox (Haredi) community in Israel through advertising campaigns, thus promoting smoking addiction among the residents of that region.


A new study led by Israeli doctoral student Amal Khayat and co-authored by Yael Bar-Zeev and researchers from the Braun School of Public Health and Community Medicine at Hebrew University in Israel was recently published in the academic journal "Tobacco Control". Titled "IQOS by PMI and cigarette advertising in the Israeli media: a content analysis across regulatory periods and target audience segments", the study examines the content of tobacco advertisements in Israel targeting specific groups of consumers.


Researchers analyzed marketing data from PMI to study the differences in advertising expenditures among several major population groups in Israel over the past four years, including the general population, Haredi communities, Arabic speakers, and Russian speakers.


Khayat stated, "In light of regulatory changes restricting tobacco product advertising, we have analyzed advertising expenditures for all PMI cigarette brands and IQOS brand (a heated tobacco stick introduced to the local market in December 2016).


Although restrictions on tobacco product advertising led to a significant decrease in the company's marketing expenditures, research shows that the company has been using legal loopholes in printing machines to subvert targets and maximize profits as much as possible.


Dr. Bar-Zeev explained that despite the law coming into effect, the company continued to spend nearly 3 million New Shekels on advertising, with a focus on print media. Although the law restricts print ads to one per newspaper, 40% of IQOS ads were huge double-page spreads that effectively doubled the advertising space for the product, while still being considered a single allowable ad under the law.


Another strategy utilized by PMI is to include QR codes in their advertisements, which allows readers to scan and view additional content outside of what is printed in the newspaper.


Furthermore, the advertisement shows individuals using IQOS devices to smoke in enclosed public spaces, despite laws prohibiting the use of any tobacco products in these areas. According to researchers, such ads give the impression that this behavior is legal, thereby taking advantage of the innocence of most consumers who may not be aware of these distinctions.


The study also found that prior to the enactment of this law, PMI significantly increased their advertising towards all reviewed populations, with a particular focus on the Haredi community, who had the lowest smoking rates in Israel before being targeted with PMI's marketing tactics.


According to Bar-Zeev, "Our data indicates that since introducing IQOS electronic cigarettes, 216 targeted advertisements have been released, of which 55% were created for the ultra-Orthodox community, 6% were created for the Arab public, and the rest were created for Russian-speaking audiences.


Similarly, 87% of cigarette ads are targeted towards the Haredi community, which is a surprising discovery as the company repeatedly claims to only be interested in marketing its products to existing smokers.


Bar-Zeev stated that the company is expected to focus on the population with the highest smoking rates in Israel - Arab males - rather than a population with almost no smokers.


According to research findings, Israel's 24th parliament has decided to cancel the exemption for print media advertising, but has ultimately postponed the implementation of this step for seven years. During the discussion, a series of additional restrictions were decided upon for this transition period, including the prohibition of using coupons, QR codes, and cigarette packaging that does not include mandatory plain packaging in print ads.


Bar-Zeev concluded that the restrictions were only a drop in the bucket because the study proved that tobacco companies found creative ways to continue marketing their products and addicting new generations despite the limitations. The researchers suggested that only a complete and immediate ban on all forms of advertisement, along with strict enforcement, could prevent such a scenario from happening.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
British American Tobacco (BAT)'s VELO brand launched the VELO WRKS nicotine pouch range in Sweden on November 2, 2026. The initial release features three Dual Can variants, each containing two separate flavours in a dual-compartment container. Each can holds 20 slim pouches with 8mg of nicotine per pouch and retails for SEK 52.99. According to VELO, the first release, Drop 1, is limited to 75,000 cans and will remain available until February 2027 or while stocks last. VELO positions WRKS as a platform for testing new product concepts and has introduced an online consumer feedback survey. EU trademark records show BAT applied to register VELO WRKS in March 2026 under Class 34, covering nicotine pouches, e-cigarettes, heated tobacco products and other tobacco-related goods.
product
Nov.03
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20